← Leaderboards
Wendy Donlin Washington
Opiaid, Inc.
$619,681
Attributed
$1,859,044
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,859,044 · 2
By mechanism
R44$1,582,511 · 1
R43$276,533 · 1
Top collaborators
- David Alderson Macqueen3 shared
- David Reeser3 shared
Most similar at Opiaid, Inc.
Same institution · by research overlap
- David Reeser$638,015
- Mary Beth Bobek$18,333
- Tyler Sugden$18,333
Others in their field
Other Emerging Leaders on “Opioid Use”
- Chanza Baytop · Westat, Inc.$271,217,917
- Jeffrey Reich · Sparian Biosciences, Inc.$28,894,251
- Andrew S Huhn · Johns Hopkins University$19,514,484
- Emmanuel Aja Oga · Research Triangle Institute$17,470,090
- Suparna Goswami · Univ Of North Carolina Chapel Hill$16,919,767
- Meredith C. B. Adams · Medical College Of Wisconsin$12,691,289
Research focus
Opioid UsePatient MonitoringMethadoneOpioid OverdoseOverdose DeathOverdose RiskAccelerometerMaintenanceMonitoring DeviceOpioidDevicesOpioid WithdrawalAlgorithmsBiometryBuprenorphineCessation Of LifeDoseMachine LearningAdoptionClinical TrialsCravingOpiate AddictionAcutePatient Self-Report